Showing 1 - 3 results of 3 for search 'Michel D Kazatchkine', query time: 0.02s Refine Results
  1. 1
    Antibody-based therapies for COVID-19: Can Europe move faster?

    Antibody-based therapies for COVID-19: Can Europe move faster? by Michel D Kazatchkine, Michel Goldman, Jean-Louis Vincent

    Published 2020-05-01
    Get full text
    Article
  2. 2
    "Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies.

    "Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies. by Jordan D Dimitrov, Michel D Kazatchkine, Srinivas V Kaveri, Sebastien Lacroix-Desmazes

    Published 2011-06-01
    Get full text
    Article
  3. 3
    Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.

    Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity. by Nimesh Gupta, Jerome LeGoff, Soulaima Chamat, Severine Mercier-Delarue, Olivier Touzelet, Ultan F Power, Michel D Kazatchkine, Francois Simon, Sebastien Lacroix-Desmazes, Jagadeesh Bayry, Srinivas V Kaveri

    Published 2013-01-01
    Get full text
    Article

Search Tools: